SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
304 hedge funds and large institutions have $6.83B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 109 increasing their positions, 98 reducing their positions, and 17 closing their positions.
365% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 17
173% more call options, than puts
Call options by funds: $81.1M | Put options by funds: $29.7M
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
24% more funds holding
Funds holding: 245 → 304 (+59)
11% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 98
8% more capital invested
Capital invested by funds: $6.31B → $6.83B (+$522M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$159M |
| 2 |
VAM
Visium Asset Management
New York
|
+$74.2M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$59.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.3M |
| 5 |
JP Morgan Chase
New York
|
+$36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
-$145M |
| 2 |
Bank of New York Mellon
New York
|
-$95.2M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$52.4M |
| 4 |
TA
Teachers Advisors
New York
|
-$43.3M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$39.9M |
SLXP Hedge Fund Activity: Q1 2014 in Review
304 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q1 2014, worth a combined $6.83B — up 8.3% from $6.31B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new SLXP positions and 17 closed out — a net gain of 62 holders — while 109 added to existing stakes and 98 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $159M. The largest seller was TIAA CREF Investment Management, cutting an estimated $145M.
- 304 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q1 2014, up from 245 in Q4 2013.
- Funds reported $6.83B of SALIX PHARMACEUTICALS LTD DEL stock for Q1 2014, up 8.3% quarter-over-quarter.
- 79 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q1 2014 and 17 closed out, a net change of +62 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q1 2014 was Viking Global Investors, an estimated $159M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q1 2014 was TIAA CREF Investment Management, an estimated $145M sold.
Based on aggregated 13F filings for Q1 2014.